Skip to main content
Log in

Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure

  • Original
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

As there is still little information available on hepatic resection in patients with chronic renal failure (CRF) in the literature, it is believed that a liver resection for HCC in CRF patients with various related complications is always risky.

Methods

We retrospectively reviewed the clinical and pathological records of 17 patients with CRF who had undergone hepatectomy for HCC, and of 51 non-CRF patients subjected to hepatectomy for HCC during the same period.

Results

The operative and pathological findings were comparable between the two groups. Postoperative circulatory insufficiency occurred more frequently in the CRF group (P = 0.013). Although the disease-free survival rates were comparable between the two groups, the overall survival rates were significantly lower in the CRF group than in the non-CRF group (P = 0.031).

Conclusions

A hepatectomy for HCC should be considered even for CRF patients with various complications if careful perioperative management and suitable multidisciplinary treatment for recurrent disease are provided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Moran JE, Prosl F. Totally implantable subcutaneous devices for hemodialysis access. Contrib Nephrol 2004;142:178–192.

    Article  PubMed  Google Scholar 

  2. Santoro A, Canova C, Feyrie A, Mancini E. Vascular access for hemodialysis. J Nephrol 2006;19(3):259–264.

    PubMed  Google Scholar 

  3. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999;354(9173):93–99.

    Article  PubMed  CAS  Google Scholar 

  4. Cuckovic C, Djukanovic L, Jankovic S, Stanojcic A, Dragicevic P, Radmilovic A, et al. Malignant tumors in hemodialysis patient. Nephron 1996;73(4):710–712.

    PubMed  CAS  Google Scholar 

  5. Locatelli F, Pozzoni P, Tentori F, Vecchio LD. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant 2003;18Suppl 7:2–9.

    Google Scholar 

  6. Sharma R, Pellerin D, Brecker SJ. Cardiovascular disease in end stage renal disease. Minerva Urol Nefrol 2006;58(2):117–131.

    PubMed  CAS  Google Scholar 

  7. Varma R, Garrick R, McClung J, Frishman WH. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease. Cardiol Rev 2005;13(2):98–107.

    Article  PubMed  Google Scholar 

  8. Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urol Nefrol 2004;56(3):279–288.

    PubMed  CAS  Google Scholar 

  9. Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006;19(4):291–296.

    Article  PubMed  Google Scholar 

  10. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ. Neutrophil apoptosis and dysfunction in urema. J Am Soc Nephrol 1999;10(1):90–100.

    Google Scholar 

  11. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58(4):1758–1764.

    Article  PubMed  CAS  Google Scholar 

  12. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001;120(6):1883–1887.

    Article  PubMed  CAS  Google Scholar 

  13. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006;19(4):317–322.

    Article  PubMed  Google Scholar 

  14. Borlase B, Simon JS, Hermann G. Abdominal surgery in patients undergoing chronic hemodialysis. Surgery 1987;102(1):15–18.

    PubMed  CAS  Google Scholar 

  15. Toh Y, Yano K, Takesue F, Korenaga D, Maekawa S, Muto Y, et al. Abdominal surgery for patients on maintenance hemodialysis. Surg Today 1998;28(3):268–272.

    Article  PubMed  CAS  Google Scholar 

  16. Wind P, Douard R, Rouzier R, Berger A, Bony C, Cugnenc PH. Abdominal surgery in chronic hemodialysis patients. Am Surg 1999;65(4):347–351.

    PubMed  CAS  Google Scholar 

  17. Harada A, Nakao A, Nonami T, Kobayashi H, Maruyama H, Suenaga M, et al. Partial hepatectomy for hepatocellular carcinoma in 6 hemodialysis patients. Nihon Shokakigeka Gakkai Zasshi 1993;26(9):2347–2351.

    Google Scholar 

  18. Sasaki Y, Yamada T, Ohigashi H, Doki Y, Kameyama M, Hiratsuka M, et al. Surgery for hepatocellular carcinoma in hemodialysis patients. Rinsho Toseki 2002;18(6):661–666.

    Google Scholar 

  19. Yamagata M, Kanematsu T, Matsumata T, Nishizaki T, Utsunomiya T, Sugimachi K, et al. Possibility of hepatic resection in patients on maintenance hemodialysis. Hepatogastroenterology 1993;40(3):249–252.

    PubMed  CAS  Google Scholar 

  20. Yeh CN, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 2005;11(14):2067–2071.

    PubMed  Google Scholar 

  21. Cheng SB, Wu CC, Shu KH, Ho WL, Chen JT, Yeh DC, et al. Liver resection for hepatocellular carcinoma in Patients with endstage renal failure. J Surg Oncol 2001;78(4):241–246.

    Article  PubMed  CAS  Google Scholar 

  22. Deenitchina SS, Ando T, Okuda S, Kinukawa N, Hirakata H, Nagashima A, et al. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 1995;15(1):57–65.

    Article  PubMed  CAS  Google Scholar 

  23. Kelly CJ. T cell function in chronic renal failure and dialysis. Blood Purif 1994;12(1):36–41.

    PubMed  CAS  Google Scholar 

  24. Raska K Jr, Raskova J, Shea SM, Frankel RM, Wood RH, Lifter J, et al. T cell subsets and cellular immunity in end-stage renal disease. Am J Med 1983;75(5):734–740.

    Article  PubMed  Google Scholar 

  25. Roskova J, Ghobrial K, Czerwinski DK, Shea SM, Eisinger RP, Raska K Jr. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987;147(1):89–93.

    Article  Google Scholar 

  26. Nagasue N, Kohno H, Hayashi T, Uchida M, Ono T, Yukaya H, et al. Repeated hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 1996;83(1):127–131.

    Article  PubMed  CAS  Google Scholar 

  27. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229(2):216–222.

    Article  PubMed  CAS  Google Scholar 

  28. Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 2006;244(2):265–273.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Orii, T., Takayama, T., Haga, I. et al. Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure. Surg Today 38, 329–334 (2008). https://doi.org/10.1007/s00595-007-3634-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-007-3634-1

Key words

Navigation